ExpandedFacilities ChemGenes recently expanded its manufacturing facilities in Wilmington, MA, signaling capacity growth and potential for higher-volume or new nucleic acid chemistry orders from academic, biotech, and pharma customers.

NucleicAcidLeader As the world’s most experienced DNA and RNA manufacturing company with a long track record since 1981, ChemGenes positions itself as a trusted supplier for nucleic acid building blocks, enabling sensitive sourcing of high-quality materials for diagnostics and therapeutics.

GlobalReach Serving academic institutions and biopharma globally, ChemGenes’ broad range of modified chemistries and life-science building blocks presents cross-market upsell opportunities across research, vaccine, and diagnostic programs.

FinancialHealth With reported revenue in the mid-range of tens of millions, there is room to scale with strategic partnerships, contract manufacturing, or co-development deals to support larger projects and long-term engagements.

TechnologyFit Existing tech stack and nimbleness suggest opportunities to tailor offerings for customers needing rapid prototyping, customized nucleic acid chemistries, or scale-up support aligned with clinical and commercial timelines.